Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:defunct |
2019
|
| gptkbp:founded |
1986
|
| gptkbp:founder |
Harry Stratford
|
| gptkbp:headquarters_location |
gptkb:Dublin,_Ireland
gptkb:Basingstoke,_United_Kingdom |
| https://www.w3.org/2000/01/rdf-schema#label |
Shire Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Adderall
gptkb:Lialda gptkb:Vyvanse Elaprase FIRAZYR |
| gptkbp:numberOfEmployees |
~5,000 (2017)
|
| gptkbp:specializesIn |
immunology
neuroscience hematology rare diseases gastrointestinal diseases |
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
SHPG
|
| gptkbp:tradedOn |
gptkb:London_Stock_Exchange
gptkb:NASDAQ |
| gptkbp:website |
www.shire.com
|
| gptkbp:bfsParent |
gptkb:extended-release_capsule_(Adderall_XR)
gptkb:Route_128_corridor gptkb:Fosrenol gptkb:Lialda gptkb:Carbatrol |
| gptkbp:bfsLayer |
7
|